Artromaksimum Martino 0.31g (60 capsules) (pain in the joints)

Artromaksimum Artromaksimum Martiniya - drug for reduction of inflammatory processes of joints and reduction of risk of development of gout Artromaksimum is made on the basis of dry extract of a martiniya fragrant (a devil claw). Roots of a martiniya contain iridoidny glycosides (garpagozid), flavonoids (kempferol, lyuteolin), triterpenovy glycosides, a large amount of carbohydrates and have unique properties. Contained garpogozid has ability to suppress inflammatory reaction at molecular level. The mobility of joints improves, the pain syndrome decreases, hypostases decrease. Atromaksimum with a martiniya is recommended for use in prevention of diseases of joints of degenerative dystrophic character. Artromaksimum with a martiniya sposobstvuyet1: to decrease in the increased level of uric acid and risk of developing gout, decrease in muscular tension, improvement of mobility and flexibility of joints and a backbone, reduction of inflammatory processes of joints and decrease in pains, increase in physical activity. Structure extract of Martini fragrant, components of the capsule (nutritional supplements): gelatin, iron oxide, titanium dioxide (dyes), cellulose microcrystalline (carrier), silicon dioxide amorphous and magnesium stearate (agents antislezhivayushchy). Content is 4 capsules (daily reception) and % of the adequate level of daily consumption of Martiniya fragrant extract, including garpagozid, not menee2 960 mg14 mg – 70% of the Recommendation about use by the Adult – on 2 capsules 2 times a day. Reception duration — not less than 1 month. If necessary reception can be repeated. Contraindications Individual intolerance of the dietary supplement components, pregnancy, feeding by a breast. Before use it is recommended to consult with the doctor. Certificate of state registration (SWAMP-SUBORS) No. KZ.16.01.97.003.E.000181.01.16 of 25.01.2016. The form of release of the Number of Capsules Capsule on 0.31 g the Expiration date to Store 3 years Storage conditions in packing of 60 capsules at a temperature not above 25 °C of 1 the Report on clinical trial, Russia, 2015 2 According to TU 9100-676-21428156-15